Nef is a key protein involved in the pathway of HIV infectivity. Nef binds to the SH3 domain of the Src family of kinases, although its role in infectivity is still unclear. Using a newly developed assay for Nef-SH3 binding the investigators will use high-throughput screening of 40,000 fungal extracts for binding to the Nef-SH3 complex. After confirmation of activity, active extracts will be selected for initial purification and characterization of active principles.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI041807-01
Application #
2421642
Study Section
Special Emphasis Panel (ZRG5-ARRD (01))
Project Start
1997-08-01
Project End
1998-01-31
Budget Start
1997-08-01
Budget End
1998-01-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Osi Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Uniondale
State
NY
Country
United States
Zip Code
11553